Chenodal (Retrophin, Inc.)
Welcome to the PulseAid listing for the Chenodal drug offered from Retrophin, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Retrophin, Inc. |
| NON-PROPRIETARY NAME: | Chenodiol |
| SUBSTANCE NAME: | CHENODIOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-12-28 |
| END MARKETING DATE: | 0000-00-00 |
Chenodal HUMAN PRESCRIPTION DRUG Details:
| Item Description | Chenodal from Retrophin, Inc. |
| LABELER NAME: | Retrophin, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2015-12-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68974-876_277566fc-6896-45e7-913d-b7a74291f07f |
| PRODUCT NDC: | 68974-876 |
| APPLICATION NUMBER: | ANDA091019 |
Other CHENODIOL Pharmaceutical Manufacturers / Labelers:
